Next Article in Journal
Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
Next Article in Special Issue
[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
Previous Article in Journal
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Review

Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives

1
Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, 91534 Paris-Saclay, France
2
Departement of Anapathology, Gustave Roussy Cancer Campus, 94805 Villejuif, France
3
Department of Hematology Gustave Roussy Cancer Campus, 94800 Villejuif, France
4
Cell Environment, DNA damages R&D, Oncology section, 75020 Paris, France
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(4), 91; https://doi.org/10.3390/cancers10040091
Received: 20 February 2018 / Revised: 20 March 2018 / Accepted: 23 March 2018 / Published: 26 March 2018
(This article belongs to the Special Issue Hodgkin's Lymphoma)
The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has provided exceptional insights into several areas of tumor biology. Findings in HL have not only improved our understanding of human carcinogenesis, but have also pioneered its translation into the clinics. HL is a successful paradigm of modern treatment strategies. Nonetheless, approximately 15–20% of patients with advanced stage HL still die following relapse or progressive disease and a similar proportion of patients are over-treated, leading to treatment-related late sequelae, including solid tumors and organ dysfunction. The malignant cells in HL are characterized by a highly altered genomic landscape with a wide spectrum of genomic alterations, including somatic mutations, copy number alterations, complex chromosomal rearrangements, and aneuploidy. Here, we review the chromosomal instability mechanisms in HL, starting with the cellular origin of neoplastic cells and the mechanisms supporting HL pathogenesis, focusing particularly on the role of the microenvironment, including the influence of viruses and macrophages on the induction of chromosomal instability in HL. We discuss the emerging possibilities to exploit these aberrations as prognostic biomarkers and guides for personalized patient management. View Full-Text
Keywords: Hodgkin lymphoma; genomic instability; microsatellite; telomeres; micronucleus; viral infections Hodgkin lymphoma; genomic instability; microsatellite; telomeres; micronucleus; viral infections
Show Figures

Figure 1

MDPI and ACS Style

Cuceu, C.; Hempel, W.M.; Sabatier, L.; Bosq, J.; Carde, P.; M’kacher, R. Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives. Cancers 2018, 10, 91. https://doi.org/10.3390/cancers10040091

AMA Style

Cuceu C, Hempel WM, Sabatier L, Bosq J, Carde P, M’kacher R. Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives. Cancers. 2018; 10(4):91. https://doi.org/10.3390/cancers10040091

Chicago/Turabian Style

Cuceu, Corina, William M. Hempel, Laure Sabatier, Jacques Bosq, Patrice Carde, and Radhia M’kacher. 2018. "Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives" Cancers 10, no. 4: 91. https://doi.org/10.3390/cancers10040091

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop